STOCK FUTURES CLIMB AS RALLY LOOKS SET TO CONTINUE

Equities rallied at end of last week, getting a boost from a "Goldilocks" U.S. jobs print

Akebia Therapeutics, Inc. (AKBA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

1.3700

+0.0700

(+5.38%)

At close: 04:00PM EDT

1.4100

+0.04

(+2.92%)

Pre-Market:

08:54AM EDT

Currency in USD

Earnings Estimate	Current Qtr. (Mar 2024)	Next Qtr. (Jun 2024)	Current Year (2024)	Next Year (2025)
No. of Analysts	3	3	3	3
Avg. Estimate	-0.08	-0.06	-0.29	-0.32
Low Estimate	-0.11	-0.08	-0.37	-0.58
High Estimate	-0.05	-0.03	-0.22	0.08
Year Ago EPS	-0.14	-0.06	-0.28	-0.29

Revenue Estimate	Current Qtr. (Mar 2024)	Next Qtr. (Jun 2024)	Current Year (2024)	Next Year (2025)
No. of Analysts	3	3	3	3
Avg. Estimate	46.09M	49.51M	188.51M	164.39M
Low Estimate	40.1M	45.79M	186.37M	125.9M
High Estimate	56M	54M	191.06M	198.6M
Year Ago Sales	40.13M	56.38M	194.62M	188.51M
Sales Growth (year/est)	14.90%	-12.20%	-3.10%	-12.80%

Earnings History	2023-03-30	2023-06-29	2023-09-29	2023-12-30
EPS Est.	-0.15	-0.02	-0.08	-0.04
EPS Actual	-0.14	-0.06	-0.08	0
Difference	0.01	-0.04	0	0.04
Surprise %	6.70%	-200.00%	0.00%	100.00%

EPS Trend	Current Qtr. (Mar 2024)	Next Qtr. (Jun 2024)	Current Year (2024)	Next Year (2025)
Current Estimate	-0.08	-0.06	-0.29	-0.32
7 Days Ago	-0.08	-0.06	-0.29	-0.32
30 Days Ago	-0.08	-0.06	-0.29	-0.29
60 Days Ago	-0.09	-0.06	-0.28	-0.08
90 Days Ago	-0.09	-0.06	-0.28	-0.08

EPS Revisions	Current Qtr. (Mar 2024)	Next Qtr. (Jun 2024)	Current Year (2024)	Next Year (2025)
Up Last 7 Days	N/A	N/A	N/A	N/A
Up Last 30 Days	N/A	N/A	N/A	N/A
Down Last 7 Days	N/A	N/A	N/A	N/A
Down Last 30 Days	N/A	N/A	1	1

Growth Estimates	AKBA	Industry	Sector(s)	S&P 500
Current Qtr.	42.90%	N/A	N/A	N/A
Next Qtr.	N/A	N/A	N/A	N/A
Current Year	-3.60%	N/A	N/A	N/A
Next Year	-10.30%	N/A	N/A	N/A
Next 5 Years (per annum)	N/A	N/A	N/A	N/A
Past 5 Years (per annum)	N/A	N/A	N/A	N/A